Validea’s guru fundamental report for BOSTON SCIENTIFIC CORP (BSX) shows it rates highest with the P/E/Growth Investor model, based on Peter Lynch’s strategy. BSX is a large-cap growth stock in the Medical Equipment & Supplies industry, with a rating of 69% based on fundamentals and valuation. The stock meets some criteria like EPS growth rate and total debt/equity ratio, but fails on sales and P/E ratio. Peter Lynch, a legendary mutual fund manager, has a common-sense approach to investing and is known for his high returns. Validea is an investment research service that follows strategies of investment legends like Lynch.

Read more at Nasdaq Inc.: Peter Lynch Detailed Fundamental Analysis – BSX